Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations (Unaudited)

v3.23.2
Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating expenses:        
Research and development $ 10,836 $ 15,164 $ 24,836 $ 31,453
General and administrative 3,055 3,077 5,376 6,426
Total operating expenses 13,891 18,241 30,212 37,879
Loss from operations (13,891) (18,241) (30,212) (37,879)
Other income (expense)        
Grant income 429   780 0
Interest income 159 77 612 150
Interest expense (2,932) (935) (4,108) (1,165)
Total other expense (2,344) (858) (2,716) (1,015)
Net Loss $ (16,235) $ (19,099) $ (32,928) $ (38,894)
Net loss per common share outstanding, basic $ (2.00) $ (2.50) $ (4.06) $ (5.20)
Net loss per common share outstanding, diluted $ (2.00) $ (2.50) $ (4.06) $ (5.20)
Weighted average number of common shares outstanding, basic 8,127,473 7,652,170 8,110,661 7,485,355
Weighted average number of common shares outstanding, diluted 8,127,473 7,652,170 8,110,661 7,485,355